Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Mc2 Therapeutics A/S
Headquarters: Hoersholm, Denmark
Website: http://www.mc2therapeutics.co...
Year Founded: 2006
Status: Private
BioCentury | Oct 17, 2023
Deals
Oct. 16 Quick Takes: Novo turns to Singapore’s KBP for hypertension asset
Plus: Gout company Atom raises $83M and updates from AbbVie, BeiGene, Amgen, Daiichi and MoonLake
BioCentury | Oct 12, 2023
Product Development
MC2's Hsp90 inhibitor shows signs of efficacy in hidradenitis suppurativa
Readout sets up ‘first-in-class’ therapy for Phase IIb study in increasingly competitive inflammatory disease
BioCentury | Aug 31, 2023
Finance
Aug. 31 Quick Takes: Sage downsizes, reveals executive departures
Plus: CCM launches with $25M+ and updates from Kangpu, Clock Bio, MC2, Huadong and RabPharma
BioCentury | Jun 9, 2022
Management Tracks
Goldstein becomes president and CMO at Aurion
Plus Duke to be CFO at Apexigen and updates from MC2, Pillar, Nonagen and more
BioCentury | May 6, 2020
Management Tracks
Abrams resigns as Editas CMO; plus Immunocore, Spruce, Frazier, Horama and more
BioCentury | Aug 31, 2018
Clinical News
MC2's non-greasy psoriasis cream superior to Taclonex in Phase III
Items per page:
1 - 7 of 7